These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 31735289)

  • 1. Fibroblasts Fuel Immune Escape in the Tumor Microenvironment.
    De Jaeghere EA; Denys HG; De Wever O
    Trends Cancer; 2019 Nov; 5(11):704-723. PubMed ID: 31735289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy.
    Barrett RL; Puré E
    Elife; 2020 Dec; 9():. PubMed ID: 33370234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling.
    Chen PY; Wei WF; Wu HZ; Fan LS; Wang W
    Front Immunol; 2021; 12():671595. PubMed ID: 34305902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts.
    Ziani L; Chouaib S; Thiery J
    Front Immunol; 2018; 9():414. PubMed ID: 29545811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment.
    Monteran L; Erez N
    Front Immunol; 2019; 10():1835. PubMed ID: 31428105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of the fibroblast activation protein α-targeted immunotherapy strategy.
    Jiang GM; Xu W; Du J; Zhang KS; Zhang QG; Wang XW; Liu ZG; Liu SQ; Xie WY; Liu HF; Liu JS; Wu BP
    Oncotarget; 2016 May; 7(22):33472-82. PubMed ID: 26985769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3-COX2-dependent pathway.
    Li A; Chen P; Leng Y; Kang J
    Oncogene; 2018 Nov; 37(45):5952-5966. PubMed ID: 29980788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy.
    Liu T; Han C; Wang S; Fang P; Ma Z; Xu L; Yin R
    J Hematol Oncol; 2019 Aug; 12(1):86. PubMed ID: 31462327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
    Piper M; Mueller AC; Karam SD
    Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAFs and T cells interplay: The emergence of a new arena in cancer combat.
    Chen M; Chen F; Gao Z; Li X; Hu L; Yang S; Zhao S; Song Z
    Biomed Pharmacother; 2024 Aug; 177():117045. PubMed ID: 38955088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer.
    Yamauchi M; Gibbons DL; Zong C; Fradette JJ; Bota-Rabassedas N; Kurie JM
    Matrix Biol; 2020 Sep; 91-92():8-18. PubMed ID: 32442601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between cancer-associated fibroblasts and immune cells in cancer.
    An Y; Liu F; Chen Y; Yang Q
    J Cell Mol Med; 2020 Jan; 24(1):13-24. PubMed ID: 31642585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response.
    Xiao Y; Wang Z; Gu M; Wei P; Wang X; Li W
    Clin Exp Med; 2024 Jun; 24(1):126. PubMed ID: 38864912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.
    Zhang H; Yue X; Chen Z; Liu C; Wu W; Zhang N; Liu Z; Yang L; Jiang Q; Cheng Q; Luo P; Liu G
    Mol Cancer; 2023 Oct; 22(1):159. PubMed ID: 37784082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment.
    Yang L; Li A; Lei Q; Zhang Y
    J Hematol Oncol; 2019 Nov; 12(1):125. PubMed ID: 31775797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression.
    Laplagne C; Domagala M; Le Naour A; Quemerais C; Hamel D; Fournié JJ; Couderc B; Bousquet C; Ferrand A; Poupot M
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Tumor Cell Dedifferentiation Drives Immune Evasion and Resistance to Immunotherapy.
    Li J; Stanger BZ
    Cancer Res; 2020 Oct; 80(19):4037-4041. PubMed ID: 32554552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-Associated Fibroblasts Affect Intratumoral CD8
    Kato T; Noma K; Ohara T; Kashima H; Katsura Y; Sato H; Komoto S; Katsube R; Ninomiya T; Tazawa H; Shirakawa Y; Fujiwara T
    Clin Cancer Res; 2018 Oct; 24(19):4820-4833. PubMed ID: 29921731
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterogeneous cancer-associated fibroblasts: A new perspective for understanding immunosuppression in pancreatic cancer.
    Zhang Z; Zhang H; Shi L; Wang D; Tang D
    Immunology; 2022 Sep; 167(1):1-14. PubMed ID: 35569095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.